Results 131 to 140 of about 19,342 (221)

Arrhythmias: antiarrhythmic agents.

open access: yesCanadian family physician Medecin de famille canadien, 2013
Arrhythmias and sudden cardiac death resulting from ventricular tachycardia/fibrillation are important public health issues of this decade. Complexities surrounding the subject, plus a relatively experimental and toxic therapeutic armamentarium with poorly defined end points, have largely limited the field to the specialized cardiologist.
openaire   +1 more source

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine. [PDF]

open access: yesPharmacol Res Perspect, 2015
Gualdani R   +6 more
europepmc   +1 more source

Dofetilide in atrial fibrillation: A comprehensive review. [PDF]

open access: yesIndian Pacing Electrophysiol J
Mahendru D, Joshi HD, Kowey P.
europepmc   +1 more source

Home - About - Disclaimer - Privacy